1Serruys PW, de Jaegere P, Kiemeneij F, et al. A comparison of balloon-expandable-stent implantation with ballon angioplasty in patients with coronary artery disease [ J ]. N Engl J Med, 1994,331 (8) :489. 被引量：1
2Fischman DL, Leon MB, Bairn DS, et al. A randomized comparison of coronary-stent placement and ballon angio- plasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators [ J ]. N Engl J Med, 1994, 331(8) :496. 被引量：1
3Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accmpolished with intravascular ultrasound guidance [ J ]. Circulation, 1995,91 ( 6 ) : 1 676. 被引量：1
4Camenzind E,Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern[ J]. Circulation, 2007,115 ( 11 ) : 1 440. 被引量：1
5Rinfret S,Cohen D J, Tahami Monfared AA, et al. Cost effec tiveness of the sirolimus - eluting stent in high - risk patients in Canada: an analysis from the C-SIRIUS trial[ J]. Am J Cardiovascular Drugs, 2006,6 ( 3 ) : 159. 被引量：1
6Stone GW,Moses JW, Ellis SG, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents [ J ]. N Engl J Med, 2007, 356(10) :998. 被引量：1
7Matetzky S, Shenkman B, Guetta V, et al. Clopidogrel resistance is associated with increased risk of recurrent athero-thrombotic events in patients with acute myocardial infarction [ J ]. Circulation, 2004,109 ( 25 ) : 3 171. 被引量：1
8Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors and outcomes of thrombosis after successful implantation of drug-eluting stents [ J]. JAMA ,2005,293(17) :2 126. 被引量：1
9Grines CL,Bonow RO,Casry DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents[J]. Circulation,2007,115(6):813. 被引量：1
3Ong AT, Hoyc A,Aoki J,et al. Thirty day incidence and sixmonth clinical outcome of thrombotic stent occlusion after bare metal,sirolimus,or paclitaxel stem implantation[J]. J Am Coll Cardiol,2005,45(6) :947-953. 被引量：1
4Cutlipd E,Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions[J]. Circulation,2007,115(17):2344-2351. 被引量：1
5I.scher TF, Steffel J, Eberli FR,et al. Drug eluting stent and coronary thrombosis : biological mechanisms and clinical implications[J]. Circulation, 2007,115(8): 1051-1058. 被引量：1
6de la Torre Hernandez JM,Alfonso F,Hern ndez F,et al. Drugeluting stent thrombosis: results from the multicenter Spanish registry ESTROFA[J]. J Am Coll Cardiol,2008,,51(10):986- 990. 被引量：1
7Joner M, Finn AV, Farb A, et al. Pathology of drug eluting stents in humans:delayed healing and late thrombotic risk[J]. J Am Coll Cardiol, 2006,48( 1 ) : 193-202. 被引量：1
9Hikita H,Kuroda S,Kawaguchi N,et al.Differential characteristics of inflammatory responses to stent implantation between de novo and intrastent restenosis lesion in patients with stable angina[J].Angiology,2012,63(2):92-95. 被引量：1
10Hao PP,Chen YG,Wang XI,et al.Efficacy and safety of drug-eluting stents in patients with acute ST-segment-elevation myocardial infarction:flmeta-analysis of randomized controlled trials[J].Tex Hcart Inst,2010,37:516-524. 被引量：1
